Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01212822
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:00.486109+00:00
Published At
2022-09-07T00:00:00+00:00
Record Updated At
2022-09-07
Results Posted At
2022-09-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adenocarcinoma of the Esophagus", "Adenocarcinoma of the Gastroesophageal Junction", "Diffuse Adenocarcinoma of the Stomach", "Intestinal Adenocarcinoma of the Stomach", "Mixed Adenocarcinoma of the Stomach", "Squamous Cell Carcinoma of the Esophagus", "Stage IA Esophageal Cancer", "Stage IA Gastric Cancer", "Stage IB Esophageal Cancer", "Stage IB Gastric Cancer", "Stage IIA Esophageal Cancer", "Stage IIA Gastric Cancer", "Stage IIB Esophageal Cancer", "Stage IIB Gastric Cancer", "Stage IIIA Esophageal Cancer", "Stage IIIA Gastric Cancer", "Stage IIIB Esophageal Cancer", "Stage IIIB Gastric Cancer", "Stage IIIC Esophageal Cancer", "Stage IIIC Gastric Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-09-07"
protocolSection.identificationModule.nctId
"NCT01212822"
protocolSection.identificationModule.officialTitle
"Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-09-07"

Study condition terms

  • Adenocarcinoma of the Esophagus (protocolSection.conditionsModule.conditions)
  • Adenocarcinoma of the Gastroesophageal Junction (protocolSection.conditionsModule.conditions)
  • Diffuse Adenocarcinoma of the Stomach (protocolSection.conditionsModule.conditions)
  • Intestinal Adenocarcinoma of the Stomach (protocolSection.conditionsModule.conditions)
  • Mixed Adenocarcinoma of the Stomach (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Esophagus (protocolSection.conditionsModule.conditions)
  • Stage IA Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IA Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IB Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IB Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIA Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIA Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIB Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIB Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Gastric Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.